Petmed Express Inc

Petmed Express Inc

  • Price (USD)23.16
  • Today's Change0.41 / 1.80%
  • Shares traded593.12k
  • 1 Year change-0.22%
  • Beta0.6145
Data delayed at least 15 minutes, as of Dec 10 2019 21:00 GMT.
More ▼

Profile data is unavailable for this security.

About the company

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

  • Revenue in USD (TTM)274.56m
  • Net income in USD26.41m
  • Incorporated1996
  • Employees199.00
  • Location
    Petmed Express Inc420 S Congress AveDELRAY BEACH 33445-4693United StatesUSA
  • Phone+1 (561) 426-4444
  • Fax+1 (800) 600-8285
  • Websitehttps://www.1800petmeds.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Taxus Pharmaceuticals Holdings Inc500.00-51.42k258.36m--------516,711.30-0.0008-0.00080.00001-0.00020.0676-------694.86-------4,052.00---10,284.00-----------90.44--56.24------
HLS Therapeutics Inc56.88m-6.96m401.72m525.00--2.1315.807.06-0.3233-0.32332.648.110.17611.074.22---2.16-3.00-2.44-3.3796.41---12.24-9.481.730.1420.3334---18.20-5.65-306.86--8.99-30.92
Rite Aid Corporation21.57bn-450.92m443.39m53.10k--0.4618--0.0206-8.51-8.62407.1917.502.298.8810.82406,187.50-4.793.18-6.794.5521.4123.89-2.091.340.8450.48010.80110.000.5137-3.25-2,592.91---10.29--
Petmed Express Inc274.56m26.41m467.25m199.0017.813.7216.301.701.301.3013.526.231.878.08168.851,379,683.0017.9925.0220.4828.4229.8533.459.6210.585.35--0.0062.023.513.968.4416.0068.989.94
Homology Medicines Inc2.08m-98.75m817.72m184.00--3.17--392.57-2.43-2.430.05145.870.0071----16,798.39-33.75---36.05-------4,740.78------0.00-------90.77------
Prestige Consumer Healthcare Inc952.66m-33.93m1.96bn520.00--1.76--2.06-0.6454-0.645418.4122.150.2663.376.431,832,044.00-0.94741.78-0.98781.8557.5556.78-3.566.401.222.900.61190.00-6.2810.31-150.23--30.55--
Data as of Dec 10 2019. Currency figures normalised to Petmed Express Inc's reporting currency: US Dollar USD

Institutional shareholders

51.46%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20192.87m14.24%
Renaissance Technologies LLCas of 30 Sep 20191.62m8.04%
The Vanguard Group, Inc.as of 30 Sep 20191.38m6.83%
Dimensional Fund Advisors LPas of 30 Sep 2019866.93k4.30%
SSgA Funds Management, Inc.as of 30 Sep 2019853.32k4.23%
SG Americas Securities LLCas of 30 Sep 2019677.50k3.36%
BofA Securities, Inc.as of 30 Sep 2019588.90k2.92%
Numeric Investors LLCas of 30 Sep 2019546.57k2.71%
Newtyn Management LLCas of 30 Sep 2019526.00k2.61%
Penserra Capital Management LLCas of 30 Sep 2019450.32k2.23%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.